About the Authors
- Alessandra Cesano
-
* E-mail: Alessandra.Cesano@Nodality.com
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- Santosh Putta
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- David B. Rosen
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- Aileen C. Cohen
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- Urte Gayko
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- Kavita Mathi
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- John Woronicz
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- Rachael E. Hawtin
-
Affiliation Nodality, Inc., South San Francisco, California, United States of America
- Larry Cripe
-
Affiliations Eastern Cooperative Oncology Group (ECOG), Boston, Massachusetts, United States of America, Indiana University Simon Cancer Center, Indianapolis, Indiana, United States of America
- Zhuoxin Sun
-
Affiliations Eastern Cooperative Oncology Group (ECOG), Boston, Massachusetts, United States of America, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
- Martin S. Tallman
-
Affiliations Eastern Cooperative Oncology Group (ECOG), Boston, Massachusetts, United States of America, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
- Elisabeth Paietta
-
Affiliations Eastern Cooperative Oncology Group (ECOG), Boston, Massachusetts, United States of America, Montefiore Medical Center North Division, Bronx, New York, United States of America
Competing Interests
AC, SP, DBR, ACC, UG, JW, and REH are employees and shareholders of Nodality, Inc., the funder of this study. KM is a consultant for Nodality, Inc. LC, ZS, MST, and EP have no competing interests. There are no products in development or marketed products to declare; however, the authors have submitted two patents entitled “METHODS FOR DIAGNOSIS, PROGNOSIS, AND METHODS FOR TREATMENT” (Application # US 2011/0104717, Published May 5th, 2011 and Application # 14/293673, Filed November 22nd, 2012) on a subset of the findings. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AC SP DBR UG LC EP. Performed the experiments: DBR JW KM. Analyzed the data: AC SP DBR ACC UG REH ZS EP JW KM. Contributed reagents/materials/analysis tools: EP LC ZS MST. Wrote the paper: AC SP DBR ACC UG REH LC ZS MST EP.